Stay updated on BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated to v3.4.3.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 was added and the previous Revision: v3.4.1 notice was removed. These changes appear to be administrative and do not modify study data or participation details.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide funding-status notice was added at the top of the page and the revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedThe updates are minor UI/label changes, including a glossary toggle, a new 'Revision: v3.4.0' label, and small wording/capitalization tweaks to update-related fields (e.g., 'Last Update' criteria and 'No FEAR Act Data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page revision was updated from v3.3.3 to v3.3.4, and no substantive study details, eligibility criteria, or contacts were changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a new Locations section listing Colorado, Georgia, Illinois, Massachusetts, New York, South Carolina, and Texas, and removed the state-specific location blocks and the HHS Vulnerability Disclosure link. The revision tag updated to v3.3.3.SummaryDifference0.9%

Stay in the know with updates to BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.